{"id":"W2094704437","doi":"10.1007/s00280-007-0442-7","title":"O6-benzylguanine and BCNU in multiple myeloma: a phase II trial","year":2007,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Carmustine; Medicine; Multiple myeloma; Neutropenia; Internal medicine; Chemotherapy; Bone marrow; Toxicity; Oncology; Gastroenterology; Regimen; Pharmacology; Etoposide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001850785,0.002549106,0.005171712,0.0008538488,0.0007218362,0.001412166,0.00162666,0.003119276,0.005435832],"category_scores_gemma":[0.001238049,0.0008805651,0.002271927,0.001107481,0.001878225,0.001621775,0.0007524775,0.006615468,0.00114186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001478579,"about_ca_system_score_gemma":0.002292545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002809779,"about_ca_topic_score_gemma":0.004964499,"domain_scores_codex":[0.999228,0.0003470507,0.0000336543,0.0001453896,0.00005868692,0.0001871149],"domain_scores_gemma":[0.9988835,0.0002236897,0.0001462086,0.0001124434,0.00004282069,0.0005912394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.859578,0.03231996,0.001472783,0.0008504522,0.001687289,0.0001847718,0.0001979167,0.001853594,0.01358264,0.0003622359,0.003723462,0.08418686],"study_design_scores_gemma":[0.8284084,0.1648154,0.002086796,0.00003959835,0.000404378,0.0001120983,0.00003277867,0.0003677212,0.001431881,0.0001990442,0.002082287,0.00001962428],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797417,0.01054837,0.000608671,0.002007583,0.000564854,0.001985191,0.001267905,0.0001951804,0.003080684],"genre_scores_gemma":[0.9747269,0.01041577,0.001440172,0.002219287,0.0007796497,0.002712313,0.002168386,0.00008099006,0.005456431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005435832,"threshold_uncertainty_score":0.01818466,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04729938861380173,"score_gpt":0.412195691664822,"score_spread":0.3648963030510203,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}